Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 7 studies | 28% ± 11% | |
microglial cell | 4 studies | 21% ± 3% | |
myeloid cell | 3 studies | 24% ± 3% | |
GABAergic neuron | 3 studies | 32% ± 16% | |
glutamatergic neuron | 3 studies | 31% ± 8% | |
monocyte | 3 studies | 19% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 29% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 96% | 97.50 | 2548 / 2642 | 85% | 7.60 | 597 / 705 |
skin | 78% | 254.19 | 1404 / 1809 | 35% | 2.27 | 164 / 472 |
breast | 84% | 97.00 | 385 / 459 | 27% | 1.09 | 297 / 1118 |
adrenal gland | 72% | 31.29 | 185 / 258 | 30% | 2.00 | 70 / 230 |
ovary | 88% | 74.78 | 158 / 180 | 9% | 0.19 | 40 / 430 |
spleen | 94% | 65.29 | 227 / 241 | 0% | 0 | 0 / 0 |
kidney | 49% | 12.56 | 44 / 89 | 44% | 2.94 | 396 / 901 |
lung | 63% | 20.49 | 363 / 578 | 12% | 0.43 | 133 / 1155 |
adipose | 62% | 35.62 | 748 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 59% | 18.29 | 549 / 929 | 0% | 0 | 0 / 0 |
prostate | 51% | 16.75 | 125 / 245 | 8% | 0.17 | 38 / 502 |
thymus | 34% | 10.47 | 223 / 653 | 17% | 1.09 | 105 / 605 |
bladder | 24% | 5.29 | 5 / 21 | 6% | 0.30 | 32 / 504 |
heart | 30% | 8.99 | 255 / 861 | 0% | 0 | 0 / 0 |
esophagus | 3% | 0.51 | 39 / 1445 | 24% | 0.84 | 44 / 183 |
intestine | 17% | 5.07 | 166 / 966 | 5% | 0.14 | 28 / 527 |
uterus | 13% | 2.84 | 22 / 170 | 9% | 0.21 | 42 / 459 |
stomach | 6% | 1.12 | 22 / 359 | 7% | 0.23 | 20 / 286 |
pancreas | 3% | 0.77 | 9 / 328 | 8% | 0.12 | 15 / 178 |
blood vessel | 8% | 1.93 | 103 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 8% | 0.14 | 6 / 80 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.11 | 3 / 45 |
liver | 5% | 0.78 | 11 / 226 | 1% | 0.10 | 5 / 406 |
muscle | 0% | 0.04 | 2 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0060080 | Biological process | inhibitory postsynaptic potential |
GO_0014069 | Cellular component | postsynaptic density |
Gene name | INSYN2B |
Protein name | Protein INSYN2B (Inhibitory synaptic factor family member 2B) |
Synonyms | FAM196B C5orf57 |
Description | |
Accessions | A6NMK8 ENST00000377365.4 |